Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450771 · ClinicalTrials.gov registry record · NA
Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID
A NA study of Avoidant/Restrictive Food Intake Disorder, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT04450771 is a NA study of Avoidant/Restrictive Food Intake Disorder that has completed, run by Stanford University. The registered enrollment target is 98 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04450771, a NA study of Avoidant/Restrictive Food Intake Disorder, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is examining the efficacy and mechanism of family therapy compared to usual care for children between the ages of 6 and 12 who are diagnosed with Avoidant/Restrictive Food Intake Disorder. Preliminary data suggest that family therapy is superior to usual care and that improvement in parental self-efficacy related to feeding their children is the mechanism of treatment. In addition, this study will attempt to identify specific patient groups who respond to family therapy.
Conditions Studied
Interventions
- BEHAVIORAL Family-based Treatment for ARFID
- BEHAVIORAL Manualized Non-Specific Usual Care for ARFID
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2026-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04450771
The ClinicalTrials.gov registry entry for NCT04450771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Avoidant/Restrictive Food Intake Disorder appearing as the primary indexed condition, and to 2 interventions - of which Family-based Treatment for ARFID is the first listed.
NCT04450771 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04450771 about?
NCT04450771 is a clinical study titled "Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID". This study is examining the efficacy and mechanism of family therapy compared to usual care for children between the ages of 6 and 12 who are diagnosed with Avoidant/Restrictive Food Intake Disorder. Preliminary data suggest that family therapy is superior to usual care and that improvement in paren...
What is the current status of trial NCT04450771?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2020-12-01. Estimated completion is 2026-01-16.
What conditions does trial NCT04450771 study?
This clinical trial studies the following conditions: Avoidant/Restrictive Food Intake Disorder.
What interventions are being tested in trial NCT04450771?
The interventions under investigation include: Family-based Treatment for ARFID (BEHAVIORAL), Manualized Non-Specific Usual Care for ARFID (BEHAVIORAL).
Who is sponsoring clinical trial NCT04450771?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04450771 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Avoidant/Restrictive Food Intake Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.